Atom Investors’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.61M Sell
145,342
-89,081
-38% -$1.79M 0.19% 188
2025
Q4
$5.49M Sell
234,423
-57,539
-20% -$1.25M 0.44% 57
2025
Q3
$5.82M Sell
291,962
-25,634
-8% -$460K 0.44% 58
2025
Q2
$4.35M Sell
317,596
-82,964
-21% -$796K 0.39% 63
2025
Q1
$4.43M Buy
400,560
+254,828
+175% +$2.72M 0.55% 49
2024
Q4
$1.55M Buy
+145,732
New +$1.74M 0.19% 154
2024
Q3
Sell
-144,780
Closed -$2.43M 614
2024
Q2
$2.43M Buy
144,780
+94,990
+191% +$1.35M 0.24% 132
2024
Q1
$747K Sell
49,790
-10,375
-17% -$170K 0.09% 262
2023
Q4
$902K Buy
60,165
+44,505
+284% +$578K 0.16% 198
2023
Q3
$219K Buy
+15,660
New +$251K 0.05% 366
2019
Q3
Sell
-62,863
Closed -$2.26M 441
2019
Q2
$2.26M Buy
+62,863
New +$2.32M 0.15% 174

Other funds holding URGN